Profile

PhD, University of Warsaw
MSc, University of Warsaw




Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Lynch JA, Berse B, Rabb M, Mosquin P, Chew R, West SL, Coomer N, Becker D, Kautter J. Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013. BMC Cancer. 2018 03 20; 18(1):306. PMID: 29554880; PMCID: PMC5859516; DOI: 10.1186/s12885-018-4190-3;
     
  2. Lynch JA, Rothney MP, Salup RR, Ercole CE, Mathur SC, Duchene DA, Basler JW, Hernandez J, Liss MA, Porter MP, Wright JL, Risk MC, Garzotto M, Efimova O, Barrett L, Berse B, Kemeter MJ, Febbo PG, Dash A. Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assay. Am J Manag Care. 2018 01; 24(1 Suppl):S4-S10. PMID: 29337486
     
  3. Hull LE, Lynch JA, Berse BB, DuVall SL, Chun DS, Venne VL, Efimova OV, Icardi MS, Kelley MJ. Clinical Impact of 21-Gene Recurrence Score Test Within the Veterans Health Administration: Utilization and Receipt of Guideline-Concordant Care. Clin Breast Cancer. 2018 04; 18(2):135-143. PMID: 29306660
     
  4. Berse B, Lynch JA, Bowen S, Grosse SD. In Reference to: "Cost and Utility of Thrombophilia Testing". J Hosp Med. 2017 09; 12(9):783. PMID: 29056884; PMCID: PMC5647890; DOI: 10.12788/jhm.2818;
     
  5. Efimova O, Berse B, Denhalter DW, DuVall SL, Filipski KK, Icardi M, Kelley MJ, Lynch JA. Clinical decisions surrounding genomic and proteomic testing among United States veterans treated for lung cancer within the Veterans Health Administration. BMC Med Inform Decis Mak. 2017 05 30; 17(1):71. PMID: 28558785; PMCID: PMC5450357; DOI: 10.1186/s12911-017-0475-8;
     
  6. Lynch JA, Berse B, Coomer N, Kautter J. 21-Gene recurrence score testing among Medicare beneficiaries with breast cancer in 2010-2013. Genet Med. 2017 Oct; 19(10):1134-1143. PMID: 28333918; DOI: 10.1038/gim.2017.19;
     
  7. Lynch JA, Berse B, Dotson WD, Khoury MJ, Coomer N, Kautter J. Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data. Genet Med. 2017 Aug; 19(8):890-899. PMID: 28125086; DOI: 10.1038/gim.2016.209;
     
  8. Chun DS, Berse B, Venne VL, DuVall SL, Filipski KK, Kelley MJ, Meyer LJ, Icardi MS, Lynch JA. BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines. Fam Cancer. 2017 Jan; 16(1):41-49. PMID: 27589855; DOI: 10.1007/s10689-016-9921-5;
     
  9. Lynch JA, Berse B, Chun D, Rivera D, Filipski KK, Kulich S, Viernes B, DuVall SL, Kelley MJ. Epidermal Growth Factor Receptor Mutational Testing and Erlotinib Treatment Among Veterans Diagnosed With Lung Cancer in the United States Department of Veterans Affairs. Clin Lung Cancer. 2017 Jul; 18(4):401-409. PMID: 28038980; DOI: 10.1016/j.cllc.2016.11.018;
     
  10. Lynch J, DuVall SL, Berse B, Whatley A, St Pierre C, Oloruntoba O, Hunt CM. Implementation of Pharmacogenetic Testing Within the Veterans Health Administration From 2011 to 2013. Mil Med. 2016 Oct; 181(10):1375-1381. PMID: 27753578
     
Showing 10 of 65 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.



Contact for Mentoring: